Moreover, our results reveal that it is possible to restore TLR3 expression in aggressive tumor cells via IFN-1 pre-treatment, and that the addition of Poly(I:C) dsRNA is then sufficient to trigger TLR3-induced cell death in vitro and in vivo, notably in osteosarcoma models. The gene discussed is TLR3; the disease is osteosarcoma.